ATE218205T1 - Vorrichtung zur simulation des einflusses des lebenden organismus auf die formveraenderung; das zufalls- und aufloeseverhalten bzw. die wirkstoffabgabe einer pharmazeutischen darreichungsform - Google Patents

Vorrichtung zur simulation des einflusses des lebenden organismus auf die formveraenderung; das zufalls- und aufloeseverhalten bzw. die wirkstoffabgabe einer pharmazeutischen darreichungsform

Info

Publication number
ATE218205T1
ATE218205T1 AT94925402T AT94925402T ATE218205T1 AT E218205 T1 ATE218205 T1 AT E218205T1 AT 94925402 T AT94925402 T AT 94925402T AT 94925402 T AT94925402 T AT 94925402T AT E218205 T1 ATE218205 T1 AT E218205T1
Authority
AT
Austria
Prior art keywords
dosage form
container
pct
head portion
piston
Prior art date
Application number
AT94925402T
Other languages
English (en)
Inventor
Joel Sinnreich
Christian Bosshard
Original Assignee
Novartis Erfind Verwalt Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Erfind Verwalt Gmbh filed Critical Novartis Erfind Verwalt Gmbh
Application granted granted Critical
Publication of ATE218205T1 publication Critical patent/ATE218205T1/de

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F21/00—Dissolving
    • B01F21/10—Dissolving using driven stirrers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N13/00—Investigating surface or boundary effects, e.g. wetting power; Investigating diffusion effects; Analysing materials by determining surface, boundary, or diffusion effects
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F31/00—Mixers with shaking, oscillating, or vibrating mechanisms
    • B01F31/44—Mixers with shaking, oscillating, or vibrating mechanisms with stirrers performing an oscillatory, vibratory or shaking movement
    • B01F31/441—Mixers with shaking, oscillating, or vibrating mechanisms with stirrers performing an oscillatory, vibratory or shaking movement performing a rectilinear reciprocating movement
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F31/00—Mixers with shaking, oscillating, or vibrating mechanisms
    • B01F31/44—Mixers with shaking, oscillating, or vibrating mechanisms with stirrers performing an oscillatory, vibratory or shaking movement
    • B01F31/445—Mixers with shaking, oscillating, or vibrating mechanisms with stirrers performing an oscillatory, vibratory or shaking movement performing an oscillatory movement about an axis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N13/00—Investigating surface or boundary effects, e.g. wetting power; Investigating diffusion effects; Analysing materials by determining surface, boundary, or diffusion effects
    • G01N2013/006—Dissolution of tablets or the like

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
AT94925402T 1993-08-06 1994-07-28 Vorrichtung zur simulation des einflusses des lebenden organismus auf die formveraenderung; das zufalls- und aufloeseverhalten bzw. die wirkstoffabgabe einer pharmazeutischen darreichungsform ATE218205T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH234993 1993-08-06
PCT/EP1994/002485 WO1995004923A1 (en) 1993-08-06 1994-07-28 Apparatus for simulating the effect of the living organism on the change in shape, the disintegration and dissolution behaviour and the active-ingredient release of a pharmaceutical dosage form

Publications (1)

Publication Number Publication Date
ATE218205T1 true ATE218205T1 (de) 2002-06-15

Family

ID=4231718

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94925402T ATE218205T1 (de) 1993-08-06 1994-07-28 Vorrichtung zur simulation des einflusses des lebenden organismus auf die formveraenderung; das zufalls- und aufloeseverhalten bzw. die wirkstoffabgabe einer pharmazeutischen darreichungsform

Country Status (8)

Country Link
US (1) US5827984A (de)
EP (1) EP0712490B1 (de)
JP (1) JP3421770B2 (de)
AT (1) ATE218205T1 (de)
AU (1) AU7533494A (de)
CA (1) CA2167196A1 (de)
DE (1) DE69430701T2 (de)
WO (1) WO1995004923A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9504893D0 (en) * 1995-03-10 1995-04-26 Cortecs Ltd Testing vessel
US6434847B1 (en) * 1999-11-02 2002-08-20 Varian, Inc. Methods and apparatus for determining the location of a shaft within a vessel
ATE270194T1 (de) * 2000-11-04 2004-07-15 Kurz Leonhard Fa Kunststoffkörper als folie, z.b. transferfolie oder laminierfolie ausgebildet oder mit einer solchen folie versehen sowie verfahren zur herstellung eines mehrfarbenbildes auf oder in einem solchen kunststoffkörper
US6336739B1 (en) * 2001-03-02 2002-01-08 Luke Lee Air bath dissolution tester
ES2266594T3 (es) * 2001-10-11 2007-03-01 Elan Pharma International Limited Aparato y metodo para monitorizar simultaneamente la liberacion activia y la apariencia fisica de formas farmaceuticas de dosificacion solida.
US20030091630A1 (en) * 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
US7357046B2 (en) * 2002-12-16 2008-04-15 N. V. Organon Method for dissolution testing of a pharmaceutical delivery device
ES2293084T3 (es) * 2002-12-16 2008-03-16 N.V. Organon Recipiente, metodo y aparato para la prueba de disolucion de un dispositivo de administracion farmaceutica.
US7051606B2 (en) * 2004-01-30 2006-05-30 Andrx Labs Llc Dosage form holder device and methods for immersion testing
CA2586447C (en) * 2004-11-05 2013-10-01 Smithkline Beecham Corporation Pharmaceutical analysis apparatus and method
FI20050385A0 (fi) * 2005-04-14 2005-04-14 Jukka Rantanen Menetelmä ja laitteisto kiinteän aineen liuottamiseksi nesteeseen
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
WO2007086470A1 (ja) * 2006-01-30 2007-08-02 Toyama Sangyo Co., Ltd. 口腔内崩壊錠試験器
JP5701596B2 (ja) * 2007-05-04 2015-04-15 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅ ＬＬＣ 医薬分析の装置および方法
CA2696227A1 (en) * 2007-10-17 2009-04-23 Transpharma Medical Ltd. Dissolution rate verification
DE102008024840B3 (de) * 2008-05-23 2009-11-12 Merck Patent Gmbh Vorrichtung zur Aufnahme eines Feststoffes in einer Messzelle
US7938032B2 (en) * 2008-10-30 2011-05-10 Agilent Technologies, Inc. Dissolution testing with in-situ gravimetric volume measurement
EP2284821A1 (de) * 2009-08-07 2011-02-16 Nederlandse Organisatie voor toegepast -natuurwetenschappelijk onderzoek TNO Verfahren, Vorrichtung und Computerprogrammprodukt zur Beurteilung der Desintegration einer Dosierform im Verdauungstrakt
JP5576337B2 (ja) * 2010-06-30 2014-08-20 ローム アンド ハース カンパニー 医薬剤形を溶出試験装置に分配するための送達装置
US8689439B2 (en) 2010-08-06 2014-04-08 Abbott Laboratories Method for forming a tube for use with a pump delivery system
US8377001B2 (en) 2010-10-01 2013-02-19 Abbott Laboratories Feeding set for a peristaltic pump system
US8377000B2 (en) 2010-10-01 2013-02-19 Abbott Laboratories Enteral feeding apparatus having a feeding set
KR101094962B1 (ko) * 2011-10-21 2011-12-15 한국지질자원연구원 광물 용해실험 장치
ITTO20120730A1 (it) * 2012-08-14 2014-02-15 Fond Istituto Italiano Di Tecnologia Dispositivo e metodo per determinare la cinetica di dissoluzione di nanoparticelle colloidali
ITRM20130163A1 (it) * 2013-03-18 2014-09-19 Univ Roma Dispositivi e metodo per testare film sottili e strisce
GB2515197B (en) * 2014-07-10 2015-06-24 Cambtek Ltd Improved extraction apparatus
WO2016168445A1 (en) 2015-04-17 2016-10-20 Pion Inc. Apparatus and method for the assessment of concentration profiling and permeability rates
JP6213933B2 (ja) * 2015-05-29 2017-10-18 有限会社サキダス 攪拌装置、メタン発酵装置及びバイオマス処理システム
CN105784952A (zh) * 2016-05-25 2016-07-20 延边大学 简易型流通池溶出度试验装置
EP3279618B1 (de) * 2016-08-01 2021-02-24 Harro Höfliger Verpackungsmaschinen GmbH Kalibriereinrichtung und verfahren zur dosierung von darreichungseinheiten
JP7603582B2 (ja) * 2019-04-08 2024-12-20 塩野義製薬株式会社 溶出試験用網
JP7261655B2 (ja) * 2019-05-15 2023-04-20 日立造船株式会社 消化器官における薬剤の溶解試験装置
US10732080B1 (en) * 2019-10-14 2020-08-04 Sotax Corporation Integrated dissolution processing and sample transfer system
CN113058448A (zh) * 2021-03-26 2021-07-02 南昌大学第二附属医院 一种体外诊断试剂的预溶解装置
CN113433277B (zh) * 2021-08-08 2022-04-01 湖南慧泽生物医药科技有限公司 药物体外溶出的循环溶出仪系统及检测药物溶出的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2530065A (en) * 1946-12-18 1950-11-14 Sterling Drug Inc Serine synthesis
US3618395A (en) * 1970-04-09 1971-11-09 Welsh Tablet disintegration apparatus
US3791221A (en) * 1972-04-07 1974-02-12 Warner Lambert Co Dissolution testing device
US3802272A (en) * 1973-01-24 1974-04-09 Dow Chemical Co Automatic dissolution rate determinator
DE2409222C2 (de) * 1974-02-27 1975-11-13 Sandoz Ag, 8500 Nuernberg Tablettenzerfallstester
DE2530065C3 (de) * 1975-07-05 1980-10-30 Dr. Madaus & Co, 5000 Koeln Vorrichtung zur Bestimmung der Zerfallszeit von Tabletten
GB2136123B (en) * 1983-03-04 1986-10-29 Akbar Noormohammadi Dissolution testing machine
DE3715961A1 (de) * 1987-05-13 1988-11-24 Pharma Test Apparatebau Gmbh Vorrichtung zur messung der aufloesegeschwindigkeit von tabletten
DE3804688A1 (de) * 1988-02-15 1989-08-24 Erweka Apparatebau Gmbh Zerfallstestgeraet
US4855821A (en) * 1988-02-16 1989-08-08 Swon James E Video timing device for pharmaceutical tablet testing
US5412979A (en) * 1993-05-03 1995-05-09 Temple University - Of The Commonwealth System Of Higher Education Method and apparatus for dissolution testing of a dosage form

Also Published As

Publication number Publication date
JPH09501238A (ja) 1997-02-04
EP0712490B1 (de) 2002-05-29
WO1995004923A1 (en) 1995-02-16
CA2167196A1 (en) 1995-02-16
DE69430701T2 (de) 2002-11-07
JP3421770B2 (ja) 2003-06-30
EP0712490A1 (de) 1996-05-22
US5827984A (en) 1998-10-27
AU7533494A (en) 1995-02-28
DE69430701D1 (de) 2002-07-04

Similar Documents

Publication Publication Date Title
ATE218205T1 (de) Vorrichtung zur simulation des einflusses des lebenden organismus auf die formveraenderung; das zufalls- und aufloeseverhalten bzw. die wirkstoffabgabe einer pharmazeutischen darreichungsform
Srinivasan et al. Enabling bone formation in the aged skeleton via rest-inserted mechanical loading
Harper et al. Stimulation of human spermatozoa with progesterone gradients to simulate approach to the oocyte: Induction of [Ca2+] i oscillations and cyclical transitions in flagellar beating
Stener-Victorin et al. A prospective randomized study of electro-acupuncture versus alfentanil as anaesthesia during oocyte aspiration in in-vitro fertilization
Bowers The effect of demands for honesty on reports of visual and auditory hallucinations
Lepe et al. Wettability, imbibition, and mass change of disinfected low-viscosity impression materials
MX9700277A (es) Sistema de procesamiento de imagenes que utiliza palanca de mando analogica.
HUT63954A (en) Process for producing active ingredient containing microparticldes from hydrolytically degredable polymers
ATE317290T1 (de) Methoden und vorrichtung zur lokalen zufuhr von parfümierten aerosolen
IT1274879B (it) Apparecchio e metodo per preparare forme farmaceutiche solide a rilascio controllato del principio attivo.
Kadow-Romacker et al. Effect of mechanical stimulation on osteoblast-and osteoclast-like cells in vitro
AR012939A1 (es) Inhalador.
ATE420681T1 (de) Modulare vorrichtung zur verabreichung von medikamenten
UA26455C2 (uk) Лікарський препарат у формі таблеток із сповільhеhим вивільhеhhям активhого іhгредієhта
ATE208612T1 (de) Biologisch erodierbare vorrichtung zur verabreichung von wirkstoffen
BR0016884A (pt) Aerossol de gota lìquida de gama-ifn e método
Loch et al. Simulation of drug distribution in the vitreous body after local drug application into intact vitreous body and in progress of posterior vitreous detachment
ATE281196T1 (de) Vorrichtung zur dosierten verabreichung eines injizierbaren produkts
DE69230317D1 (de) Verfahren und vorrichtung zum dosieren eines flüssigen arzneimittels
Judex et al. Modulation of bone’s sensitivity to low-intensity vibrations by acceleration magnitude, vibration duration, and number of bouts
ATE277682T1 (de) Vorrichtung zum herstellen eines angepassten körperpflegemittels
CL2002001701A1 (es) Uso de al menos un compuesto seleccionado entre melatonina, agentes melatoninergicos, agonistas y antagonistas de melatonina, en una cantidad de 0,0025-50 mg, para preparar un medicamento util para el tratamiento y mejora de la calidad repadora del sueno.
ES2118090T3 (es) Nuevo uso medico de un determinado derivado de indol y composicion farmaceutica que lo contiene.
Pawlak et al. Repeated nicotine treatment in rats with high versus low rearing activity: analyses of behavioural sensitisation and place preference
Sullivan et al. Constriction of environmental space and the behavioral response to the dopamine agonist quinpirole

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee